Visionary Venture Fund logo

Visionary Venture Fund

North America, California, United States, Aliso Viejo

Description

A venture capital fund that invests in the future of ophthalmology.

Investor Profile

Visionary Venture Fund has made 21 investments, with 1 in the past 12 months and 71% as lead.

Stage Focus

  • Series B (38%)
  • Series A (29%)
  • Series C (14%)
  • Series Unknown (5%)
  • Seed (5%)
  • Series H (5%)
  • Series D (5%)

Country Focus

  • United States (81%)
  • Israel (10%)
  • United Kingdom (10%)

Industry Focus

  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Biotechnology
  • Biopharma
  • Therapeutics
  • Clinical Trials
  • Information Technology
  • Chemical Engineering
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Visionary Venture Fund frequently co-invest with?

Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 3
Flying L Partners
North America, Colorado, United States, Steamboat Springs
Co-Investments: 4
Techstart Ventures
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
SBI Japan-Israel Innovation Fund
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Co-Investments: 3
ExSight Ventures
North America, New York, United States, New York
Co-Investments: 3
Bluestem Capital
North America, South Dakota, United States, Sioux Falls
Co-Investments: 5
QUBIS
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
LV
North America, New York, United States, New York
Co-Investments: 2
InFocus Capital Partners
North America, New York, United States, Jericho
Co-Investments: 2
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Visionary Venture Fund?

Orasis Pharmaceuticals

Ponte Vedra, Florida, United States

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Clinical TrialsHealth CareMedicalPharmaceutical
Series DOct 8, 2024
Amount Raised: $68,000,000
Pelage Pharma

Los Angeles, California, United States

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss.

Health CareMedicalPharmaceutical
Series AFeb 27, 2024
Amount Raised: $16,750,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 8, 2023
Amount Raised: $15,000,000
Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
Series ANov 30, 2022
Amount Raised: $12,075,997
Iantrek

White Plains, New York, United States

Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.

Health CareMedicalWellness
Series BAug 30, 2022
Amount Raised: $23,000,000
Aurion Biotechnologies

Seattle, Washington, United States

Aurion Biotechnologies is a clinical-stage biotech company.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownApr 12, 2022
Amount Raised: $120,000,000
Sydnexis

Del Mar, California, United States

Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

ManufacturingPharmaceutical
Series BAug 10, 2021
Amount Raised: $45,000,000
Orasis Pharmaceuticals

Herzliya, Tel Aviv, Israel

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Clinical TrialsHealth CareMedicalPharmaceutical
Series CSep 10, 2020
Amount Raised: $30,000,000
TearClear

Boston, Massachusetts, United States

TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.

Chemical EngineeringMedical DevicePharmaceutical
Series BAug 11, 2020
Amount Raised: $22,000,000
Re-Vana Therapeutics

Belfast, Belfast, United Kingdom

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Health CareMarket ResearchMedicalTherapeutics
SeedJun 2, 2020
Amount Raised: $3,250,000